submit urlsubmit rss feedadd directoryphysician directoryPharmacology employment

article

Ropinirole (marketed as Requip®) is a non-ergoline dopamine agonist, manufactured by GlaxoSmithKline. It is used in the treatment of Parkinson's disease, and is also the only medication in the United States with an FDA-approved indication for the treatment of restless legs syndrome.

Dosing


Requip is available in various preparations, ranging from the .25mg tablet to the 5mg tablet. The primary reason for such is dose titration. This implies that the person taking ReQuip has to closely interact and communicate with the Personal Care Physician with regard to how much should actually be taken by the patient.

More on [ Ropinirole ]


directory of related categories

 
Ropinirole RSS feed
Ropinirole - Twitter Search

Neuro: A multicentre retrospective study of the clinical use of ropinirole in the treatment of Parkinson's disease: http://url4.eu/bXwf
MDLinx (Sandeep Pulim MD) Thu, 08 Oct 2009 16:00:03 -0000
Neuro: A multicentre retrospective study of the clinical use of ropinirole in the treatment of Parkinson's disease: http://url4.eu/bXwf

 
Subscribe to Ropinirole RSS feed

directory of related sites

DrugDigest: Ropinirole ( Requip ) - Information on dosage, usage, side effects, interactions, and drug comparisons, including generics when available.

Requip - Product and prescribing information.

Ropinirole related videos

 

HOMEADVERTISINGABOUT US

articlesartsbusinesscomputersgameshealthhospitalshomekids & teensnewsmobilephysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld


Submit a Site About Become an Editor